Long-Term Statin Use Won't Up Cancer Risk: Study
New research on the cholesterol-lowering drugs supports recent findingsContinue Reading
New research on the cholesterol-lowering drugs supports recent findingsContinue Reading
The annual event, sponsored by the American Cancer Society, focuses on quitting for one dayContinue Reading
Provenge extends survival by about four months on average, costs $93,000 per individualContinue Reading
Research finds benefits of expected lives saved outweigh the dangersContinue Reading
Especially at high altitudes, skin protection is needed year-roundContinue Reading
Injected therapy believed to stifle cancer cell growthContinue Reading
Not only are more smokers quitting, but fewer people are choosing to start habit, 30-year study findsContinue Reading
Those under 40 report more widespread pain and financial difficulties than their elders, study findsContinue Reading
Testimonials, graphic images evoke response, study findsContinue Reading
U.S. survey found 69% now know about chronic obstructive pulmonary diseaseContinue Reading
But rates of prescription drug abuse are similar, survey findsContinue Reading
Study found patients with acute myeloid leukemia who had the variant were more likely to die quicklyContinue Reading
Study finds link between hormone Rx, colorectal tumors, but absolute risk is small, experts sayContinue Reading
Images would include emaciated lung cancer patients and a dead body in a morgueContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.